| Product Code: ETC12345589 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Latvia saw a steady growth in the import shipments of HCV direct-acting antivirals, with top exporting countries including Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the diverse sources of imports, market concentration remained low in terms of HHI. The compound annual growth rate (CAGR) from 2020 to 2024 was strong at 8.6%, indicating a robust market expansion. Moreover, the growth rate from 2023 to 2024 stood at a healthy 7.03%, signaling continued momentum in the Latvian market for HCV treatments.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia HCV Direct Acting Antiviral Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia HCV Direct Acting Antiviral Market - Industry Life Cycle |
3.4 Latvia HCV Direct Acting Antiviral Market - Porter's Five Forces |
3.5 Latvia HCV Direct Acting Antiviral Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 Latvia HCV Direct Acting Antiviral Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.7 Latvia HCV Direct Acting Antiviral Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Latvia HCV Direct Acting Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latvia HCV Direct Acting Antiviral Market Trends |
6 Latvia HCV Direct Acting Antiviral Market, By Types |
6.1 Latvia HCV Direct Acting Antiviral Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Antibody, 2022 - 2032F |
6.1.4 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Viral Load, 2022 - 2032F |
6.1.5 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Genotyping, 2022 - 2032F |
6.2 Latvia HCV Direct Acting Antiviral Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By NS3/4A Protease Inhibitors, 2022 - 2032F |
6.2.3 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By NS5A Polymerase Inhibitors, 2022 - 2032F |
6.2.4 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By NS5B Polymerase Inhibitors, 2022 - 2032F |
6.2.5 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By Combination Drugs, 2022 - 2032F |
6.3 Latvia HCV Direct Acting Antiviral Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.3.3 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
6.3.4 Latvia HCV Direct Acting Antiviral Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
7 Latvia HCV Direct Acting Antiviral Market Import-Export Trade Statistics |
7.1 Latvia HCV Direct Acting Antiviral Market Export to Major Countries |
7.2 Latvia HCV Direct Acting Antiviral Market Imports from Major Countries |
8 Latvia HCV Direct Acting Antiviral Market Key Performance Indicators |
9 Latvia HCV Direct Acting Antiviral Market - Opportunity Assessment |
9.1 Latvia HCV Direct Acting Antiviral Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 Latvia HCV Direct Acting Antiviral Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.3 Latvia HCV Direct Acting Antiviral Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Latvia HCV Direct Acting Antiviral Market - Competitive Landscape |
10.1 Latvia HCV Direct Acting Antiviral Market Revenue Share, By Companies, 2025 |
10.2 Latvia HCV Direct Acting Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here